P-glycoprotein and an unstirred water layer barring digoxin absorption in the vascularly perfused rat small intestine preparation: induction studies with pregnenolone-16alpha-carbonitrile.
Digoxin, a substrate of P-glycoprotein (Pgp) and cytochrome P450 3a (Cyp3a), was used to illustrate the inductive effects of pregnenolone-16alpha-carbonitrile (PCN), a ligand of the pregnane X receptor, on the absorption and disposition of [3H]digoxin in the vascularly perfused rat small intestine preparation. Although increased Cyp3a protein was observed with Western blotting analysis after PCN treatment, metabolism of digoxin to the digoxigenin bis-digitoxoside metabolite in the rat small intestine remained insignificant (<4% dose). PCN pretreatment significantly decreased blood perfusate [3H]digoxin concentrations for both systemic and intraluminal administrations of [3H]digoxin due to increased Pgp levels. The apical secretion by Pgp increased at 90 min with PCN treatment, from 11.2 +/- 5.1% of dose to 20.1 +/- 8.6% of dose after systemic administration of [3H]digoxin; this increase was, however, statistically insignificant (P = 0.13) because of the high variability among preparations. When the composite data for the control and PCN-treated preparations were fit to published physiologically based pharmacokinetic models: the traditional model and the segregated flow model, suboptimal parameters were obtained. The data were further fit to expanded models with a bilayer membrane compartment housing the Pgp adjacent to the apical membrane, or an unstirred water layer (UWL) external to the apical membrane. The models with the UWL yielded improved fits and reasonable parameters associated with digoxin absorption, suggesting that the UWL posed as a barrier for digoxin absorption. Similar results were obtained with the segmental models (the segmental traditional model and the segmental segregated flow model) using the UWL, when heterogeneous distributions of Pgp in the duodenum, jejunum, and ileum were considered.
Liu
Shanjun
S
Department of Pharmaceutical Sciences, University of Toronto, Toronto, Ontario, Canada.
Tam
Debbie
D
Chen
Xianghai
X
Pang
K Sandy
KS
D020168:ATP Binding Cassette Transporter, Subfamily B, Member 1 / Q000096:biosynthesis*; D000818:Animals; D001682:Biological Availability; D003198:Computer Simulation; D051544:Cytochrome P-450 CYP3A / Q000096:biosynthesis; D004077:Digoxin / Q000008:administration & dosage / Q000493:pharmacokinetics*; D004333:Drug Administration Routes; D004790:Enzyme Induction; D007408:Intestinal Absorption; D007421:Intestine, Small / Q000187:drug effects* / Q000201:enzymology; D008297:Male; D008954:Models, Biological; D010477:Perfusion / Q000379:methods; D011285:Pregnenolone Carbonitrile / Q000494:pharmacology*; D051381:Rats; D017207:Rats, Sprague-Dawley; D014316:Tritium; D014867:Water / Q000737:chemistry
D020168:ATP Binding Cassette Transporter, Subfamily B, Member 1; D014867:Water; D014316:Tritium; D011285:Pregnenolone Carbonitrile; D004077:Digoxin; D051544:Cytochrome P-450 CYP3A